세계 의료용 산소발생기 시장 규모는 예측 기간(2024-2030년) 동안 연평균 5.63% 성장할 것으로 예상됩니다. 의료용 산소발생기 수요 증가는 주로 만성폐쇄성폐질환(COPD), 수면무호흡증, 저산소혈증, 폐부종과 같은 호흡기 질환의 유병률 증가, 고령 및 침상 환자 수요 증가, 전 세계 코로나19 팬데믹 이후 의료용 산소발생기 수요 급증에 기인합니다. 이러한 요인들은 2024-2030년의 예측 기간 동안 의료용 산소발생기 시장의 성장에 기여할 것으로 예상됩니다.
의료용 산소발생기 시장 역학
제품 수요의 주요 요인은 만성폐쇄성폐질환(COPD), 수면무호흡증, 저산소혈증, 폐부종 등 호흡기 질환의 유병률 증가, 노인 및 침상 환자의 유병률 증가 등입니다.
세계보건기구(WHO)(2022)에 따르면 만성폐쇄성폐질환(COPD)은 세계 3위의 사망 원인으로, COPD는 산소 농도 저하를 억제하기 위해 산소 요법이 필요하며, COPD의 유병률 증가는 산소발생기에 대한 수요를 증가시킬 것입니다. Obstructive Lung Disease(BOLD) 보고서에 따르면 2020년 COPD로 인해 연간 300만 명에 가까운 사망자가 발생합니다. 이 자료에 따르면 COPD는 향후 40년 동안 증가할 것으로 예상되며, 2060년까지 COPD로 인해 연간 540만 명 이상이 사망할 수 있으며, COPD는 흡연율 증가와 함께 증가할 것으로 예측됩니다. 미국 질병통제예방센터(Centers for Disease Control and Prevention)에 따르면 2020년 18세 이상 미국 성인 100명 중 약 13명(12.5%)이 담배를 피우고 있습니다. 현재 미국에서는 약 3,080만 명의 성인이 담배를 피우고 있으며, 1,600만 명 이상의 미국인이 흡연과 관련된 질병을 앓고 있습니다. 이러한 흡연율 증가는 COPD의 유병률을 증가시켜 산소발생기 시장에 긍정적인 영향을 미칠 것입니다.
또한, Forum of International Respiratory Societies가 발표한 Global Impact of Respiratory Disease report(제3판, 2022)에 따르면, 2019년에 1억 명 이상이 수면호흡장애를 앓고 있는 것으로 나타났습니다. 수면무호흡증과 같은 수면장애는 산소 농도를 조절하기 위해 산소 요법을 시행하는데, 이는 의료용 산소발생기에 대한 수요를 더욱 증가시킬 것으로 예측됩니다. 스트레스가 많은 생활습관도 2024-2030년의 예측 기간 동안 젊은 층의 수면장애 증가에 기여할 것으로 보입니다.
실내 공기 오염 물질 증가와 흡연자 증가도 의료용 산소발생기 시장의 성장을 가속하는 요인입니다. 미국 폐협회(American Lung Association)에 따르면 2022년 미국인 10명 중 4명 이상이 공기 질이 좋지 않은 곳에 살고 있으며, 공기 오염에 노출될 기회가 증가하면 호흡기 질환을 유발할 수 있다고 합니다. 이 자료에 따르면, 2022년 'State of the Air'에서 오존 또는 입자상 물질 오염으로 F 등급을 받은 카운티에 1억 3,500만 명 이상이 거주하고 있습니다.
또한 많은 수의 고령 환자와 병상에 누워있는 환자도 의료용 산소발생기가 사용되는 요인 중 하나이며, Global Initiative for Chronic Obstructive Lung Disease(2020) 보고서에 따르면 COPD의 유병률은 연령에 따라 급격히 증가합니다, 60세 이상의 유병률이 가장 높은 것으로 나타났습니다. 나이가 들어감에 따라 호흡기가 약해지고 체내 산소 농도가 낮아집니다.
호흡곤란으로 알려진 호흡곤란은 65세 이상 노년층에서 많이 발생하며, 65세 이상 인구의 약 30%에서 나타납니다. 호흡 곤란은 주요 징후로 간주되며, 의료용 산소발생기는 이 증상을 치료하기 위해 제공되어 의료기기 시장 성장을 증가시킵니다.
이 보고서는 세계 의료용 산소발생기 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등의 정보를 전해드립니다.
Medical Oxygen Concentrators Market By Product (Stationary, Portable), By Technology (Continuous Flow, Pulse Flow, Both), By End-User (Homecare, Hospitals And Clinics, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to increased prevelence of respiratory disorders like chornic obstructive pulmonary disease (COPD) and increased need for medical oxygen concentrators for geriatrics and bedridden patients
The global medical oxygen concentrators market is estimated to advance at a CAGR of 5.63% during the forecast period (2024-2030). The increase in demand for Medical Oxygen Concentrators is primarily attributed to the increased prevalence of respiratory disorders like chronic obstructive pulmonary disorder (COPD), sleep apnea, hypoxemia, pulmonary edema and other respiratory illness, further increased demand in geriatric and bedridden patients, and steep rise in demand of medical oxygen concentrators after COVID-19 pandemic across the world are anticipated to bolster the market, thereby contributing to the growth of the Medical Oxygen Concentrators market during the forecast period from 2024-2030.
Medical Oxygen Concentrators Market Dynamics:
The major factors responsible for product demand is increased prevalence of respiratory disorders like chronic obstructive pulmonary disorder (COPD), sleep apnea, hypoxemia, pulmonary edema and other respiratory illness and increased prevalence of geriatric and bedridden patients.
According to World Health Organization (WHO) 2022, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death worldwide. Oxygen therapy is needed for COPD to control the oxygen level drops, increasing prevalence of COPD will increase the demand for oxygen concentrators. According to Burden of Obstructive Lung Disease (BOLD) report, 2020, there are nearly three million deaths annually due to COPD. Also as per the same source, COPD is expected to rise over the next 40 years and by 2060 there may be more than 5.4 million deaths annually due to COPD. COPD is increased with increased prevalence of smoking. As per Centers for Disease Control and Prevention, in 2020, nearly 13 of every 100 U.S. adults aged 18 years or older (12.5%) smoked cigarettes. An estimated 30.8 million adults in the United States currently smoke cigarettes and more than 16 million Americans live with a smoking-related disease. This increasing prevalence of smoking shoot up the prevalence of COPD, effecting the market of oxygen concentrators positively.
Moreover, according to the Global Impact of Respiratory Disease report (third edition, published in 2022) published by Forum of International Respiratory Societies, in 2019 more than 100 million people suffer from sleep-disordered breathing. During sleep-disorders like sleep-apnea oxygen therapy is provided to control the oxygen level, which is further expected to increase the demand for medical oxygen concentrators. Stressful lifestyle will also contribute to increase the sleep disorders in young age population during the forecasting period from 2024-2030.
Increase in indoor air pollutants as well as increase in pollution of active smokers, is also responsible for propelling the growth of the medical oxygen concentrator market. The increased exposure to air pollution can cause respiratory ailments in people. According the American Lung Association, 2022 more than four in ten Americans live where the air quality is not good. As per the same source, more than 135 million people live in counties that received an F for either ozone or particle pollution in "State of the Air" 2022.
Also, the prevalence of geriatric and bedridden patients is another factor responsible for the use of these Medical Oxygen Concentrators. According to the Global Initiative for Chronic Obstructive Lung Disease 2020 report, the prevalence of COPD increased steeply with age, with the highest prevalence among those with more than 60 years age. The respiratory system becomes weak with age, lowering the oxygen level in the body.
Dyspnea also known as shortness of breath is highly prevalent in the elderly, and is reported by approximately 30% of individuals greater than 65 years of age. In dyspnea difficulty in breathing is observed as a major symptom, medical oxygen concentrators can be provided to cure this symptom; increasing the market growth of the medical device.
Moreover, according to WHO 2022 report, between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22% and by 2030, 1 in 6 people in the world will be aged 60 years or over. The share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.
Furthermore, there was more need for oxygen concentrators during COVID-19 infection. During second wave of COVID-19 people purchased oxygen concentrators fearing the shortage of medical oxygen. Moreover, people with COVID-19 were at increased risk for pneumonia and hypoxemia, which are major predictor of mortality. People with these complications were recommended proper oxygen supply. This supply can be given by medical oxygen concentrators. This increased the demand of medical oxygen concentrators in the market. The rise in demand had led to hike in prices.
But, the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape post pandemic made the resumption of regular healthcare services, which will keep a steady demand for these products on course in the Medical Oxygen Concentrators market.
Therefore, with proper monitoring and care the mortality and hospitalization due to respiratory ailment can be prevented. Hence, the growth of the Medical Oxygen Concentrators Market is expected to rise during the forecast period from 2024 to 2030.
However, the stringent regulatory process and high cost of devices may be certain limiting factors of the Medical Oxygen Concentrators market growth.
Medical Oxygen Concentrators Market Segment Analysis:
Medical oxygen concentrators market by product (stationary, portable), by technology (continuous flow, pulse flow, both), by end-user (homecare, hospitals and clinics, others) and by geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Technology segment of the Medical Oxygen Concentrators market, the Pulse Flow segment is estimated to hold a significant market share in the year 2023. This can be ascribed to the various advantages that are associated with the pulse flow oxygen concentrators.
Pulse flow oxygen concentrators puffs oxygen into the nasal passageway, through a cannula, with each breath. In these concentrators oxygen is delivered only during inhalation and is stored during exhalation thereby saving the amount of oxygen as well as life of battery used to operate the concentrators. This is useful when the patient is doing some other activity like drinking water. These device are mostly used by the patient in daytime as compared to nighttime because the breathing rate is not steady while sleeping.
Furthermore, advantageous properties such as more energy efficiency due to rest period between two breaths, increase in battery life due to rest period and smaller size. As well, doctors' advice pulse flow oxygen concentrators in moderate to severe respiratory ailments, where these devices are effectively used.
Moreover, various new products are coming into the market which in turn depicts the high demand of these products. For instance, In March 2022, Belluscura announced that the X-PLO2R pulse flow portable oxygen concentrator manufactured by Belluscura has been granted 510(K) clearance from the U.S. Food and Drug Administration (FDA). X-PLO2R is a compact, quiet, weighing only 3.25 pounds, compact and portable oxygen concentrators.
Therefore, the advantages offered by the Pulse Flow in Medical Oxygen Concentrators are predicted to contribute to the increasing demand, thereby driving the growth of the overall Medical Oxygen Concentrators market during the forecast period.
North America is expected to dominate the overall Medical Oxygen Concentrators Market:
Among all the regions, North America is expected to account for the largest share in the global Medical Oxygen Concentrators market in the year 2023. Factors such as the growing prevalence of various respiratory ailments like COPD, hypoxia and others, increasing prevalence of geriatric and bedridden patients, increase in air pollution and smoking are some of the key factors which are expected to aid in the growth of North America Medical Oxygen Concentrators Market.
For instance, according to the WHO 2022, (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. The mortality rate can be reduced by giving emergency aid to serious patients by the providing medical oxygen concentrators to the patient, increasing the demand of device in the market.
Furthermore, as per the Centers for Disease Control and Prevention (CDC) 2022, COPD makes breathing difficult for the 16 million Americans. The difficulty in breathing can be managed by providing the medical oxygen concentrators to the patients thereby driving the market in North America.
Additionally, according to the Pan American Health Organization (PAHO), in 2019, the chronic respiratory disease accounts for 534,242 deaths in both sexes, 267,516 (50%) deaths in men and 266,725 (50%) in women. The increase in prevalence of chronic respiratory disease and deaths caused by them can be controlled by providing the patients with medical devices like oxygen concentrators and educating them about the usage of the device, will affect the market of the medical device positively.
Moreover, according to CDC, in 2020, preterm birth affected 1 of every 10 infants born in the United States. In preterm birth, organs like lungs, heart, and brain may not be fully developed. If the lungs are not developed properly then external source is used to provide oxygen to the baby. Medical oxygen concentrators can be used to provide oxygen in the above case. The prevalence is expected to rise at a significant rate in the forecast period. Thus, the burgeoning cases of premature births will contribute to the growth of the Medical Oxygen Concentrators market.
Furthermore, the government of the North America is actively involved in relevant organizations which can provide proper COPD management guidance to the patients. National Center for Immunization and Respiratory Diseases is under a mission to prevent the disease, disability, and death through immunization and to control of respiratory and related diseases. As the awareness of treatment and management of COPD will increase in the patient, use of oxygen concentrators will also increases in the market, thereby fostering the market in North America.
Therefore, the rising prevalence of these respiratory disorders in the North America would result in the rising demand for treatments that make use of Medical Oxygen Concentrators, which in turn would provide a conducive growth environment for the Medical Oxygen Concentrators market in the North American region.
Hence, the interplay of various factors such as the presence of a large respiratory ailment patient population, increased prevalence of preterm births in the region as well as awareness created among the patients by government and organizations is expected to boost the North America Medical Oxygen Concentrators market during the forecast period.
Medical Oxygen Concentrators Market Key Players:
Some of the key market players operating in the Medical Oxygen Concentrators market include Koninklijke Philips N.V., Invacare corporation, DeVilbiss Healthcare LLC, Inogen,Inc., Nidek Medical, O2 Concepts, Teijin Limited, Supera Anesthesia Innovations, GCE Group, CAIRE, OxyGo, LLC, Precision medical, Inc., Graham Field, Belluscura , Besco Medical Limited, OSI - Oxygen Solutions Inc, NGK Spark Plug Co Ltd, Yuwell (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.), Narang Medical Limited, Topson and others.
Recent Developmental Activities in the Medical Oxygen Concentrators Market:
In March 2022, Belluscura have signed a three-year manufacturing agreement for its X-PLO2r portable oxygen concentrator with InnoMax Medical Technology in China.
In March 2022, Belluscura announced that the X-PLO2R pulse-flow portable oxygen concentrator manufactured by Belluscura has been granted 510(K) clearance from the U.S. Food and Drug Administration (FDA).
In March 2022, OxyGo announced that they have acquired LIFE Corporation, a manufacturer of portable emergency oxygen and CPR administration equipment. The acquisition will allow OxyGo to further expand its expertise in the oxygen market.
Key Takeaways from the Medical Oxygen Concentrators Market Report Study
Target Audience who can be benefited from this Medical Oxygen Concentrators Market Report Study
Frequently Asked Questions for Medical Oxygen Concentrators Market:
Medical Oxygen Concentrators are medical devices that provides supplemental oxygen to the patients with breathing disorder. The device filter the surrounding air, compressing it to the required density and then deliver the purified medical grade oxygen. The device is equipped with special filters and sieve beds which helps to remove nitrogen from the air and deliver completely purified oxygen to the patient.
The global medical oxygen concentrators market is estimated to advance at a CAGR of 5.63% during the forecast period (2024-2030).
The Medical Oxygen Concentrators market is witnessing a positive market growth owing to the increased prevalence of respiratory disorders like chronic obstructive pulmonary disorder (COPD), sleep apnea and other respiratory illness, increased demand in geriatric and bedridden patients, and due to unexpected demand of medical oxygen concentrators during COVID-19 pandemic across the world are anticipated to bolster the market.
Some of the key market players operating in the Medical Oxygen Concentrators market include Koninklijke Philips N.V., Invacare corporation, DeVilbiss Healthcare LLC, Inogen,Inc., Nidek Medical India, O2 Concepts, Teijin Aramid B.V, Supera Anesthesia Innovations, GCE Group, CAIRE Inc., OxyGo, Precision medical, Inc., GF HEALTH PRODUCTS, INC., Belluscura, Besco, OSI - Oxygen Solutions Inc, NGK Spark Plug Co Ltd, Yuwell (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.), Narang Medical Limited, Topson and others.
North America is expected to hold the highest share in the revenue in the Medical Oxygen Concentrators market during the forecast period. Factors such as the growing prevalence of respiratory disorders like chronic obstructive pulmonary disorder (COPD), sleep apnea, hypoxemia, pulmonary edema and other respiratory illness and increased demand in geriatric and bedridden patients are expected to aid in the growth of the North America Medical Oxygen Concentrators Market in this region.